Reperfusion of ischemic myocardium is necessary to salvage tissue from eventual death. However, reperfusion after even brief periods of ischemia is associated with pathologic changes that represent either an acceleration of processes initiated during ischemia per se, or new pathophysiological changes that were initiated after reperfusion. This 'reperfusion injury' shares many characteristics with inflammatory responses in the myocardium. Neutrophils feature prominently in this inflammatory component of postischemic injury. Ischemia-reperfusion prompts a release of oxygen free radicals, cytokines and other proinflammatory mediators that activate both the neutrophils and the coronary vascular endothelium. Activation of these cell types promotes the expression of adhesion molecules on both the neutrophils and endothelium, which recruits neutrophils to the surface of the endothelium and initiates a specific cascade of cell-cell interactions, leading first to adherence of neutrophils to the vascular endothelium, followed later by transendothelial migration and direct interaction with myocytes. This specific series of events is a prerequisite to the phenotypic expression of reperfusion injury, including endothelial dysfunction, microvascular collapse and blood flow defects, myocardial infarction and apoptosis. Pharmacologic therapy can target the various components in this critical series of events. Effective targets for these pharmacologic agents include: (a) inhibiting the release or accumulation of proinflammatory mediators, (b) altering neutrophil or endothelial cell activation and (c) attenuating adhesion molecule expression on endothelium, neutrophils and myocytes. Monoclonal antibodies to adhesion molecules (P-selectin, L-selectin, CD11, CD18), complement fragments and receptors attenuate neutrophil-mediated injury (vascular injury, infarction), but clinical application may encounter limitations due to antigen-antibody reactions with the peptides. Humanized antibodies and non-peptide agents, x such as oligosaccharide analogs to sialyl Lewis , may prove effective in this regard. Both nitric oxide and adenosine exhibit broad spectrum effects against neutrophil-mediated events and, therefore, can intervene at several critical points in the ischemic-reperfusion response, and may offer greater benefit than agents that interdict at a single point in the cascade. The understanding of the molecular processes regulating actions of neutrophils in ischemic-reperfusion injury may be applicable to other clinical situations, such as trauma, shock and organ or tissue (i.e. vascular conduits) transplantation.
Introduction
response to injury has evolved as an immunological defense against bacterial and other invaders, the heart's Undoubtedly, reperfusion of ischemic myocardium is inflammatory reaction to injury may not be optimal, or necessary to salvage tissue from ultimate death. However, even appropriate, for its own healing in the case of reperfusion after even brief periods of ischemia submits to myocardial ischemia. At the same time that reperfusing the axiom ' . . . for every action, there is a reaction. ' blood halts the ischemic process by supplying oxygen and Although the biochemistry and physiology of the host's nutrients, a cascade of events with properties similar to the inflammatory response is rapidly initiated. However, this inflammatory-like response to ischemia-reperfusion, me-*Corresponding author. Tel.: 11-404-686-2511; fax: 11-404-686-4888.
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diated largely by neutrophils, is mounted against host 2. Mechanisms of neutrophil-mediated injury tissue, such as the endothelium and myocardium, and this 'normal' response has no system of checks and balances to Neutrophils have been implicated as a primary mechadistinguish 'self' tissue from 'non-self' and to adjust itself nism underlying ischemic-reperfusion injury. The propenaccordingly. Neutrophils play a central role in this insity to injure the myocardium and its component cells flammatory-like response to reperfusion by releasing oxid-(notably the coronary vascular endothelium, microvasculaants and proteases that damage or kill tissues, and release ture, myocytes) stems from the myocardium's primary inflammatory products that amplify the recruitment and responses to proinflammatory mediators, which leads to a activation of greater numbers of neutrophils into the redirection of the normal inflammatory response geared effected myocardium, thereby extending the severity of towards neutralizing host invaders to one that attacks the tissue damage. Hence, neutrophils are intimately involved host tissue. The processes involved in inducing tissue in the pathogenesis of myocardial infarction, vascular injury by neutrophils include oxygen free radical generaendothelial dysfunction, damage to the genetic apparatus, tion, degranulation and release of proteases, and release of apoptosis and other manifestations of lethal injury in the arachidonic metabolites and other proinflammatory mediacute phase following reperfusion. This 'reperfusion inators. jury' involves a well-orchestrated series of interactions between neutrophils and the vascular endothelium via 2.1. Oxygen free-radical generation specific adhesion molecules on both cell types; these interactions are initiated in the immediate peri-reperfusion Superoxide anions are generated from the neutrophilperiod, and may continue during the ensuing hours and membrane-associated NADPH oxidase [1, 2] , which can be days following reperfusion. These specific events appear to activated by soluble proinflammatory cytokines [N-formyl be critical and are a prerequisite to the eventual expression peptides, C5a, platelet activating factor (PAF)] and parof tissue damage. The understanding of these physiological ticulate stimuli. Adherence of neutrophils to biological processes is interesting in and of itself, but, more imsurfaces, and circulating inflammatory mediators such as portantly, it forms a basis for the therapeutic strategies tumor necrosis factor a (TNF-a) and interleukin 6 (IL-6) addressing neutrophil-mediated myocardial reperfusion prime the cells and greatly increase their response in vitro. injury discussed in the latter part of the manuscript.
Neutrophils stimulated by proinflammatory mediators If one accepts the concept of reperfusion injury, and the produce superoxide anions, hydrogen peroxide and, ulticentral involvement of neutrophils in this process, then one mately, hydroxyl radicals in a respiratory burst charactermay recognize both a window of opportunity during which ized by a high metabolic activity and consumption of drug therapy can be initiated, and an appropriate target.
oxygen. Hydrogen peroxide is formed from dismutation of This opportunity to intervene is available to cardiologists superoxide anions after the release of myeloperoxidase at the time of coronary catheterization or entry into the from azurophilic granules. A sensitive target of oxygen emergency care facility, and to cardiac surgeons using free-radical injury is the vascular endothelium. Oxygen cardioplegia as a vector for drug delivery or for various free radicals promote the release of proinflammatory intravenous drugs in cases of off-pump cardiac surgery.
mediators from endothelial cells and other sources, which Actually, reperfusion provides a broad gateway to treating leads to the expression of adhesion molecules on endothe multiple, and often redundant, mechanisms involved in thelium [3] . Endothelial damage mediated by oxyradicals postischemic injury. The neutrophil-mediated inflammaresults in increased permeability [4] [5] [6] , increased adhertory cascade during reperfusion represents one such imence of neutrophils [7] , attenuated release of endotheliumportant target for therapeutic intervention because of the derived factors with anti-neutrophil properties, such as pivotal role played by the neutrophil in deleterious events nitric oxide and adenosine, and overexpression of endofollowing reflow. However, effective therapeutic strategies thelium-derived pro-inflammatory factors. In addition, targeting the cause or propagation of the myocardium's oxygen free radicals oxidize low density lipoprotein (LDL) response to ischemic-reperfusion injury, rather than to its to pro-atherogenic products, which may represent a link symptoms, are predicated on the knowledge of its molecubetween oxyradical generation by neutrophils and heart lar basis. This article discusses the role of the neutrophil in disease. Furthermore, superoxide anions derived from the inflammatory component of ischemic-reperfusion inneutrophils may be a substrate in the formation of peroxjury, and potential therapeutic strategies targeting neutroynitrite, derived from the biradical reaction between neuphil-mediated reperfusion injury of the heart. The majority trophil-derived superoxide anion and nitric oxide [8] [9] [10] [11] [12] [13] . of the discussion focuses on lethal injury following However, hypochlorous acid is the predominant cytotoxic prolonged ischemia, and focuses little on non-lethal injury molecule derived from neutrophils. Its cytotoxicity derives (i.e. myocardial 'stunning') because the predominant data from production of powerfully oxidizing chloramines. In (but not the entirety) suggest that neutrophils do not addition to directly injuring tissue, oxygen free radicals participate in the pathogenesis of this manifestation of may provide a leukotactic signal by (a) stimulating the injury.
generation of complement, (b) inducing expression of P-selectin on endothelium and (c) inducing surface expreswhich, in turn, prevents conformation of shape to capillary sion of PAF on endothelium.
dimensions. Hence, activated neutrophils embolize in precapillary vessels, thereby contributing to microvascular 2.2. Degranulation products resistance and 'no-reflow' [17] . Other causes of embolization include homotypic aggregation of platelets and neutroNeutrophils degranulate to release proteases, collagenphils, and endothelial cell swelling. ases, lipoxygenases, phospholipases, and myeloperoxidase (Table 1) . The serine protease, elastase, is a major contributor to neutrophil-mediated damage, due partially to 3. Neutrophils and endothelial dysfunction from the effect of its highly cationic nature on membrane charge reperfusion injury distribution. Elastase also hydrolyzes the extracellular matrix components elastin, fibronectin and collagen types Endothelial dysfunction plays a critical role in the III and IV.
pathogenesis of reperfusion injury in the myocardium [18] [19] [20] [21] . This role stems from the close proximity of the 2.3. Arachidonic acid metabolites and platelet activating endothelium to neutrophils and other inflammatory cell factor types at the vascular interface during the critical early phase as well as the later phase of reperfusion. The Neutrophil activation stimulates phospholipase A and interaction between neutrophils and endothelial cells is 2 generates leukotriene B (LTB ) and PAF. LTB and PAF mediated by a well orchestrated sequence of interactions 4 4 4 are potent stimulants of neutrophil chemotaxis, degranulabetween adhesion molecules on both the endothelium and tion and adhesion to endothelial cells, which may thereby neutrophils. These adhesion molecules are categorized into amplify neutrophil recruitment and neutrophil-mediated three families: (a) selectins, (b) b -integrins and (c) the
. PAF also stimulates platelets, which can then immunoglobulin superfamily. The selectins (P-selectin, Lsynergize with neutrophils to amplify injury [15, 16] .
selectin, E-selectin) are glycoproteins involved in the Cytokine-induced neutrophil activation increases not only interactions between neutrophils and the endothelium early adherence properties [14] but also cytoskeletal rigidity, in reperfusion. P-selectin is not constitutively expressed on the surface of endothelial cells, but is stored in Weibel- [33, 34] ; monoclonal antibodies to PECAM-1 have been Palade bodies. P-selectin expression on the surface of reported to inhibit neutrophil transendothelial migration endothelial cells can be induced by proinflammatory [33] [34] [35] , with subsequent reduction of injury (infarction) mediators such as oxygen radicals [22] , thrombin [23] , [36] . complement components, histamine and hydrogen peroxNeutrophils are recruited to the reperfused myocardium ide. After ischemia, P-selectin surface expression peaks by chemotactic factors that are released by the myocarafter 10-20 min of reperfusion, and is subsequently shed dium during ischemia [37, 38] and begin to interact with to soluble fragments in blood [24] [25] [26] . Weyrich et al. [26] the endothelium through a process of 'rolling' (Fig. 1 ). demonstrated that P-selectin was maximally expressed in Rolling along the endothelial surface is mediated by Pfeline arterioles and venules after 90 min of ischemia and selectin on the endothelium and sialylated glycoprotein on x 20 min of reperfusion. Longer periods of reperfusion are the neutrophil, most likely sialyl Lewis or the sialomucin associated with a gradual decrease in the detected levels of P-selectin glycoprotein ligand-1 (PSGL-1) [28, 39] . This P-selectin, representing shedding of the selectin. In coninitial loose adherence is an obligatory step that is necestrast to P-selectin, L-selectin is constitutively expressed on sary for later firm adherence mediated by the CD11 / CD18 the surface of neutrophils, and may be the counterligand complex and ICAM-1, leading to transendothelial migrafor P-selectin during early reperfusion [27] . Recently, a tion into the myocardial parenchyma and their physiologihigh affinity glycoprotein ligand for P-selectin, termed cal sequellae (no-reflow, necrosis) [27, [40] [41] [42] . After initial P-selectin glycoprotein ligand-1, PSGL-1 [28] , has been tethering of neutrophils by endothelial P-selectin, a well identified, which may mediate, in part, neutrophil rolling orchestrated sequence of neutrophil-endothelial cell interon purified P-selectin [28] and on intact endothelium. The actions evolves, with the endothelial expression of adhethird member of the selectin family, E-selectin, is exsion molecules, such as E-selectin and ICAM-1, and pressed on the surface of endothelial cells. It is expressed expression of adhesion counterligands on the neutrophils, later in reperfusion (4-6 h) and may therefore be involved such as CD11 / CD18, which allow firm adherence of in later reperfusion events (discussed below). neutrophils to the endothelium. Platelet activating factor The b -integrins (CD11 / CD18 complex) are a family of [43, 44] and LTB [44] can increase the surface expression 2 4 heterodimeric glycoproteins that are constitutively exand adhesiveness of CD11 / CD18 on neutrophils, while pressed on the surface of neutrophils. There are three IL-1 [45] and TNF-a [45] increase ICAM-1 expression on distinct a-chains (CD11a, CD11b, CD11c) and a common the endothelium. Weyrich et al. [26] demonstrated that b subunit. The CD11b / CD18 complex is stored in sec-ICAM-1 levels were increased by ischemia-reperfusion. ondary granules in neutrophils. Activation of neutrophils While levels of ICAM-1 remained at a relatively low level by a number of proinflammatory mediators, including PAF, for 120 min of reperfusion, there was a significant rise in involves an increase in surface expression of CD11 / CD18 expression after 150 and 270 min. complexes (CD11b / CD18, CD11c / CD18), which is Neutrophil adherence to the coronary endothelium inachieved, in part, by rapid translocation from granules to duces functional injury to the endothelium [46] [47] [48] [49] [50] . Cothe membrane surface, or by an increase in adhesive incubation of neutrophils and healthy coronary artery rings avidity to the respective counterligands, which involves a with thrombin (or hydrogen peroxide or histamine) in conformational change and conversion from a low affinity organ chambers causes contraction of the artery, due to state to a high affinity state with exposure of functional neutralization of the vasodilator nitric oxide by superoxide epitopes. Increased surface expression and affinity state of anion, and injury-induced impairment of nitric oxide perhaps the major complex CD11b / CD18 is triggered after release (Fig. 2) . The degree of vasocontraction is paralthe rolling phase of neutrophils on the endothelium, a step leled by the number of neutrophils adherent to the corthat is a prerequisite for firm adherence mediated by onary artery endothelium. In addition, the vasocontraction interaction with its counterligand ICAM-1 on the endoresponses could be attenuated by the antibody to P-selecthelium.
tin, PB1.3, and accentuated by the nitric oxide synthase ICAM-1, VCAM-1 and platelet-endothelial cell adhesion inhibitor, L-nitro-arginine. Fig. 3 shows endothelial molecule-1 (PECAM-1) are members of the immunodysfunction after incubation of neutrophils with thrombinglobulin superfamily. ICAM-1 is the counterligand for stimulated endothelium from coronary arteries. Thrombin CD11 / CD18 on neutrophils and is constitutively expressed upregulates P-selectin and has no direct stimulatory effect on the surface of vascular endothelial cells. ICAM-1 is on neutrophils. Thrombin treatment in the absence of upregulated by cytokines 2-4 h after stimulation in vitro or neutrophils induces no discernable alterations in agonistafter myocardial ischemia-reperfusion [29, 30] and costimulated vasorelaxation responses. In contrast, co-incuincides with the upregulation of CD11 / CD18. PECAM-1 bation of neutrophils with thrombin-stimulated coronary is expressed constitutively on the surface of platelets, artery endothelium is associated with a significant decrease leukocytes and endothelial cells, and is localized to the in the concentration-response vasorelaxation curve, with a intercellular junctions of the latter [31, 32] . PECAM-1 may characteristic decrease in maximal response to the highest be involved in the transendothelial migration of neutrophils concentration of acetylcholine used. In contrast, vasorela- xation responses to the smooth muscle dilator sodium activators, such as PAF, can stimulate neutrophils to cause nitroprusside is unaltered by ischemia or exposure to damage to both the endothelium and to vascular smooth activated neutrophils. Therefore, neutrophils induce endomuscle, possibly by protease activity. thelium-specific damage to receptor-dependent and recepIn vivo ischemia and reperfusion cause injury to the tor-independent vasodilator function. Other neutrophil vascular endothelium, expressed as a reduction in basal and stimulated NO release [48, [51] [52] [53] and, hence, at-4. Neutrophil accumulation within the area at risk tenuate the response to agonist stimulators of eNOS [48, 54, 55] , which is, in large part, dependent on neutroOne of the earliest sequellae of reperfusion is the 'nophils. In models of transient coronary occlusion (,2 h), reflow' phenomenon. In a study of the no-reflow phenomendothelial dysfunction is not evident immediately after enon in canine hearts, Kloner et al. [58] demonstrated that the ischemic period in the absence of reperfusion. Howextended periods of ischemia (90 but not 40 min of ever, endothelial dysfunction is progressively expressed, ischemia) followed by reperfusion were associated with a starting as early as 2.5 min after the start of reperfusion lack of blood flow to the subendocardium. Microscopic [51] , and persists for hours [18, 51] to days [56] after examination of the myocardium within this 'no-reflow reperfusion. Tsao and Lefer [48] investigated the effect of zone' revealed severely damaged capillary structure. Enischemia and reperfusion on endothelial function. Free gler et al. [59] demonstrated the presence of leukocytes in radical production is dramatically increased during the the vessels within the 'no-reflow' zones of the myocardium early moments of reperfusion, which can be attenuated by after ischemia and reperfusion, and an overall accumularecombinant human superoxide dismutase (rhSOD), sugtion of leukocytes in the area at risk [60] . Following these gesting that free radicals may play a major role in the initial observations, Engler et al. [61] demonstrated that endothelial dysfunction that occurs early in reperfusion.
removal of neutrophils from the perfusing blood reduced The early loss of endothelial function, expressed as an the extent of no-reflow and concomitantly reduced myocarimpaired release of nitric oxide, is associated with a dial edema formation. Subsequently, other groups have progressive increase in neutrophil adherence to the endoalso implicated the accumulation of neutrophils as a major thelial surface of ischemic-reperfused coronary arteries cause of the no-reflow component of reperfusion injury as ( Fig. 4a and b) . Endothelial dysfunction may persist for well as other manifestations of reperfusion injury, includdays following reperfusion [57] . Models of in vivo global ing ventricular arrhythmias and infarct size [62] [63] [64] . ischemia generally agree with endothelial dysfunction Neutrophils are recruited to the reperfused myocardium being observed only after reperfusion [52, 53] unless more by chemotactic factors released by the myocardium during prolonged periods of ischemia are imposed [52] . As with ischemia [37, 38] . Many of these substances, including regional ischemia-reperfusion, this endothelial dysfunction TNF-a, IL-8, IL-6, PAF, complement and leukotrienes, after global ischemia is expressed as a reduction in basal will initiate the processes of adherence to the endothelium (i.e. adherence of unstimulated neutrophils to ischemicdescribed above. A link has been established between the reperfused coronary artery endothelium) as well as agonistaccumulation of neutrophils and the development of stimulated vasorelaxation responses. Endothelial dysfuncreperfusion injury during the early reperfusion period. This tion is often associated with morphological abnormalities link has been substantiated by several studies that investiin endothelial structure, including intracellular vacuolizagated the time course of neutrophil accumulation and tion, detachment from the basement membrane with exprogression of injury. In 1988, Smith et al. [65] subjected posed subendothelial matrix, loss of endothelial cell memrats to 30 min of regional myocardial ischemia followed by brane integrity and attachment of neutrophils.
reperfusion of up to 96 h. These investigators correlated dogs. This endogenous compound was able to induce morphologic changes in neutrophils, orient neutrophils along a chemotactic gradient, induce expression of b 2 integrin adhesion molecules on neutrophils (i.e. CD11 / CD18) and induce adherence of neutrophils to endothelial monolayers. The neutrophil stimulation by the cardiac lymph was found to be most potent when collected at 1 h of reperfusion and decreased to basal levels by 6 h of progressively slower rates, further supporting the theory that neutrophils play an important role in the early events the degree of morphologic injury (creatine kinase) to of reperfusion. These early events involve the initial neutrophil accumulation assessed by both histology and contact between neutrophils and the endothelium in coranalysis of myeloperoxidase (an enzyme specific to neutroonary arterioles and venules, and the process of neutrophil phil azurophilic granules) activity during ischemia and rolling [67] . reperfusion. This study demonstrated that: (a) neutrophils accumulated within the area at risk early in the reperfusion period; (b) their activity peaked during the first 24 h of 5. Role of neutrophils in late reperfusion injury reperfusion and (c) there was a positive correlation between myeloperoxidase activity and creatine kinase release Studies have demonstrated that the evolution of infarcat 24 h of reperfusion, after which time, the correlation tion is a dynamic process that takes place during the early was lost.
phase of reperfusion (,6 h) after a brief period of Subsequent to the study of Smith et al. [65] , Dreyer et ischemia. Frame et al. [68] found that binding of antial. [38] stimulation of activating chemotactic factors, local proand 48 h of reperfusion. During the first 6 h of reperfusion, duction of complement and cellular adhesion molecules neutrophils are mainly localized to the intravascular space, necessary to recruit neutrophils into the ischemic-reperwhile the majority of neutrophils at later time points are fused myocardium. Furthermore, the degree of endothelial found in the interstitial compartment. This observation is injury may be insufficient to promote neutrophil adherence consistent with histopathologic findings that neutrophils and amplify neutrophil recruitment [76] . Alternatively, the are sequestered in the intravascular compartment during actions of neutrophils may not alter the physiology of the early reperfusion (4-6 h) [71] . Early postischemic damage endpoint of interest, i.e., contractile function. However, the to the vascular endothelium mediated by neutrophils may contractile dysfunction following brief global ischemia in be initiated by direct contact with the endothelium and, which infarction may not be evident, but in which inultimately, cause damage to myocytes (infarction) by creased creatine kinase activity suggests some degree of subsequent diffusion of cytotoxic inflammatory mediators structural damage, has been observed to be neutrophilbefore direct neutrophil-myocyte contact occurs in 4-6 h.
dependent [77, 78] . In other models of lethal injury, the role However, later reperfusion injury responsible for infarct of neutrophils in the pathogenesis of endothelial dysfuncextension may involve transendothelial migration of neution and infarction is well documented. Therefore, the trophils and subsequent neutrophil-mediated myocyte inmodel and endpoints must be taken into careful considerajury. Therefore, the neutrophil-mediated response to istion when designing and interpreting experiments testing chemia and reperfusion leading to vascular and myocyte anti-neutrophil therapy to be sure that neutrophils affect damage may extend beyond the short term (4-6 h) of the physiology of the endpoint of interest. reperfusion.
6.1. Neutrophil depletion
Anti-neutrophil therapy
Neutrophil depletion can be achieved by several methods, including chemotherapy to induce systemic neutroNeutrophils feature so prominently in the etiology of penia [72, 79] , administration of anti-neutrophil antiserum ischemia-reperfusion injury in lethal models of myocardial (antibodies) or by passing systemic or regional (i.e. ischemic-reperfusion injury that therapy directed towards coronary) blood supply through neutrophil-clearing filters the processes of neutrophil activation, adherence to endo-[62, 72, 80, 81] . Neutrophil filters have also been used to thelium, emigration into the parenchyma and the release of filter blood or blood cardioplegia during cardiac surgery cytotoxic products are all candidate targets towards which [82, 83] . The reported benefits of local or systemic neutropharmacological therapy could be directed. The proximalpenia in models of severe ischemia include reduction of most processes of activation and adherence may be more postischemic arrhythmias [81] , an attenuation of postefficient targets for therapy compared to more distal ischemic 'no-reflow' in the myocardial area at risk [61, 63] , processes, or towards the symptoms of injury; the latter a decrease in postischemic microvascular permeability approach does not address the mechanisms by which the [84] , reduction in infarct size with neutrophil depletion symptoms are presented. The attenuation of neutrophilbefore reperfusion [62, 80] or at the time of reperfusion mediated injury manifested as infarction, vascular dysfunc- [63] . However, with shorter periods of ischemia, no tion and blood-flow defects and, in some cases, contractile reduction in postischemic blood flow defects has been dysfunction have been used as indirect evidence of the key reported because neutrophil adherence and plugging may role played by neutrophils in ischemic-reperfusion injury.
not be triggered by modest ischemic periods [74] . AlTherapy directed against neutrophil-mediated compothough neutrophil-specific filters are relatively efficient at nents of ischemic-reperfusion injury include (a) neutrophil removing neutrophils, they do effect other cell types, such depletion, (b) direct inhibitors of neutrophil activation, (c) as platelets, and they activate complement or release other neutrophil-specific anti-adhesion therapy with antibodies vasoactive substances (adenosine) that may modulate neuand (d) endothelium-specific anti-adhesion therapy. The trophil actions by mechanisms other than direct removal. ability of any of these interventions to attenuate neutrophilmediated damage is dependent on the role that neutrophils 6.2. Anti-adhesion molecule therapy play in the pathophysiology of the end-point of observation (infarction, contractile dysfunction, vascular dysfunction),
Interference with the neutrophils themselves or with the and the severity of the injury and, hence, the ability to initial adherence to coronary vascular endothelial cells is an effective therapeutic target since this step is a precules (decoys), may also offer a potential therapeutic requisite for neutrophil-mediated damage. Early work by strategy.
Romson et al. [62] demonstrated a reduction in infarct size
and neutrophil accumulation by administration of an 'anti-6.3. Nitric oxide therapy against neutrophil-mediated neutrophil antibody'. Interference at the earliest step of damage 'rolling', by blocking either P-selectin on the endothelium or L-selectin on the neutrophil with monoclonal antibodies, NO is an autacoid, formed primarily by the vascular has been reported to result in cardioprotection. Blockade of endothelium by the conversion of L-arginine and molecular P-selectin with monoclonal antibodies such as PB1. 3 oxygen to citrulline, and is subsequently released into the reduces infarct size and associated neutrophil accumulation intravascular compartment, the perivascular compartments in the area at risk and attenuates endothelial dysfunction and interstitium. The close proximity of newly released [40, 85, 86] . Blockade of L-selectin on neutrophils with nitric oxide to these compartments that are active in the DREG-200 [87, 88] gave a similar profile of cardioprotecpathogenesis of ischemia-reperfusion injury places NO in tion to myocardial and vascular endothelium as P-selectin a unique position to modulate biochemical reactions and blockade. Intervention with the neutrophil adhesion molecell-cell interactions that are characteristic of ischemiccule CD18 using antibodies such as MAb R15.7 [89, 90] reperfusion injury. The broad range of physiological was reported to reduce neutrophil-endothelial cell interacactions relevant to ischemic-reperfusion injury and other tions and neutrophil accumulation [66, 89] associated with cardiovascular disease states is shown in Fig. 6 . Nitric ischemia-reperfusion. In the study by Ma et al. [89] , MAb oxide has direct effects on both the neutrophil and the R15.7 reduced myocardial infarct size, attenuated neutroendothelium. In addition, NO attenuates activation of mast phil accumulation within the area at risk and attenuated cells and platelets [99, 100] with which the neutrophils endothelial cell dysfunction. Interference with ICAM-1, synergize during ischemia-reperfusion [15] . Platelets the counterligand to CD18, using monoclonal antibodies potentiate the activation and interaction of neutrophils with (RR1 / 1), has also been reported to reduce infarct size the endothelium by releasing thromboxane A (pro-adhe-2 [91, 92] , neutrophil accumulation and to attenuate endosion, pro-diapedesis), platelet derived growth factor thelial dysfunction or postischemic blood-flow defects (chemoattractant, chemotaxis), platelet factor 4 (chemotac- [92] . Other studies have used antibodies against CD11, tic), serotonin (pro-adherence), adenosine (chemotactic at CD18, the CD11 / CD18 complex or L-selectin on the low concentrations, inhibitory at higher concentrations neutrophil to decrease superoxide-induced adhesion of [101] ) and IL-8 [16] . The direct effects of NO on the neutrophils to endothelial cells, [22, 93] reduce adherence neutrophil include inhibition of superoxide anion proto myocytes [94] and to reduce ischemia-reperfusion duction, degranulation and adherence to coronary artery injury [90, 95] . Therefore, direct interference with the early endothelium [49, 102] . Inhibition of superoxide generation and prerequisite interactions between neutrophils and by neutrophils may involve a direct inhibition of memendothelium has been effective in reducing postischemic brane-bound NADPH oxidase activity [103] . In addition, injury. In addition to suggesting a therapeutic treatment, nitric oxide neutralizes superoxide anions in a very rapid these observations further substantiate the role of neutroand essentially irreversible biradical reaction to form phils in mediating the distal events of infarction and peroxynitrite [10-13]. blood-flow defects that are characteristic of severe postIn addition to direct inhibitory effects on neutrophils, ischemic injury.
nitric oxide also has direct inhibitory effects on the Antibody therapy has several potential limitations in its vascular endothelium, which subsequently attenuates its clinical application. First, the limited half-life of antibodies interaction with neutrophils. Nitric oxide attenuates the in the systemic circulation may address only the early upregulation of P-selectin, E-selectin and ICAM-1 phase of reperfusion and not the later phase (.4-6 h) of [43, 104] , adhesion molecules involved in the loose and reperfusion. Hence, antibody therapy may not sustain longfirm adherence of neutrophils to endothelium. The attenuaterm effects, as demonstrated by Gill et al. [96] for an tion of P-selectin expression involves, in part, the inhibix antibody to sialyl-Lewis , which had shown short-term tion of P-selectin messenger RNA and synthesis of the reduction of infarct size [97, 98] . Drugs with similar short P-selectin glycoprotein [105] , which may imply that nitric half-lives that are not administered continuously over oxide attenuates not only the immediate surface expression several days following reperfusion may suffer this limitaof adhesion molecules but also their longer-term exprestion, unless attenuation of the early phase prevents trigsion following ischemia and reperfusion. Through inhibigering or amplification of subsequent secondary processes.
tion of superoxide anion generation and adherence to Second, systemic antibodies may be generated to the vascular endothelium, nitric oxide attenuates neutrophiltherapeutic antibody, thereby forming an antigen-antibody mediated damage to coronary artery vascular endothelium complex. Humanized peptide receptor antagonists for [49, [106] [107] [108] [109] [110] [111] [112] [113] . various proinflammatory mediators and adhesion moleAs a result of its potent anti-neutrophil and anti-incules, as well as non-active mimetics of adhesion moleflammatory properties, NO has been reported to exert potent cardioprotection from ischemic-reperfusion injury. directly inhibit superoxide anion generation by activated Authentic nitric oxide [99, 114] or direct nitric-oxide PMNs, it does inhibit adherence of unactivated PMNs to donors [106, 108, [115] [116] [117] [118] [119] have been reported to reduce thrombin-stimulated coronary artery endothelium (Fig. 8) . infarct size and, also, to preserve coronary artery endoFurthermore, endothelial dysfunction associated with the thelial basal (static neutrophil adherence) and agonistadherence of PMNs is attenuated by L-arginine. Therefore, stimulated (relaxation responses) function. L-Arginine, the the cardioprotective effects of L-arginine may involve, in precursor of nitric oxide, increases nitric oxide generation large part, an attenuation of PMN-mediated actions that and release, and reduces postischemic injury (infarct size, would otherwise culminate in vascular injury and infarcendothelial dysfunction) in a manner similar to that of tion. nitric oxide [55, [120] [121] [122] . Conversely, inhibition of endoIn contrast to the reported cardioprotective effects of thelial nitric oxide synthase using analogs such as L-nitronitric oxide, reports have implicated nitric oxide in promarginine increases the extent of injury [123, 124] . Intravenulgating injury because of its actions as a radical, or via the ous [122] and intracoronary [55] L-arginine, administered generation of potentially deleterious metabolites such as 2 at the time of reperfusion, was shown to significantly peroxynitrite (ONOO ) and its intermediary product with decrease both postischemic coronary artery endothelial hydroxyl radical-like actions (NOOH*) [125] [126] [127] [128] [129] [130] [131] [132] . Theredysfunction and infarct size. The reduced infarct size was fore, a duality of opposing physiological actions is associassociated with a decrease in neutrophil adherence to ated with endogenous and exogenous nitric oxide therapy, coronary artery endothelium and neutrophil accumulation and the neutrophil as a generator of both nitric oxide and in the area at risk. In a study by Nakanishi et al. [55] , superoxide anion as substrates for peroxynitrite [8,9] may infusion of 10 mM L-arginine into the left anterior debe directly involved in this controversy. A detailed discusscending (LAD) coronary artery starting at the time of sion on the physiological effects of peroxynitrite has been reperfusion resulted in a significant reduction of infarct presented elsewhere [10, 12, 133] . size (Fig. 7) . However, infarct size reduction was not observed with 10 mM D-arginine, the non-metabolized 6.4. Adenosine, neutrophil function and neutrophilenantiomer of L-arginine. Myeloperoxidase activity, a related cardioprotection marker of neutrophil accumulation, increased significantly in the area at risk in the untreated group, and was Adenosine is a cardioprotective autacoid that is present significantly reduced by intracoronary L-arginine (Fig. 7B) .
in small quantities (less than 1 mM) in the normal Postischemic endothelial vasorelaxation responses to acemyocardium [134] [135] [136] and is transiently increased during tylcholine were significantly increased in the L-arginine ischemia by hydrolysis of high-energy phosphates (ATP, treated group compared to both the vehicle group and the ADP, AMP). The physiological tissue levels of adenosine D-arginine group (Fig. 7C) . Although L-arginine does not are regulated by the production and release of adenosine A receptor subtype [138] . The role of the A receptor on 2a 3 degranulation is not clear at present. by cardiac myocytes, the endothelium, neutrophils and Many studies have demonstrated that adenosine atother cell types. Adenosine interacts with specific purinertenuates the adherence of neutrophils to endothelial cells gic receptors (Table 2 ) on the endothelium, myocytes or [139] [140] [141] 144] . However, adenosine has opposing effects neutrophils to elicit a wide range of physiological reon neutrophil adherence related to the concentration-desponses that are not unlike those of NO. Therefore, pendent stimulation of the A or A adenosine receptors. (intravascular, interstitial, myocyte) involved in ischemia diated effects. However, higher concentrations inhibit and reperfusion injury. The target of these receptor-meneutrophil adherence by A receptor mechanisms. This 2a diated interactions has implications as to the time course of dual action has been confirmed by Felsch et al. [140] . administration of therapeutics.
Adenosine attenuates adherence by a down-regulation of Cronstein et al. [137] reported that adenosine inhibited b -integrin (CD11b / CD18) [145] expression and inhibi-2 superoxide generation by neutrophils activated by a numtion of L-selectin shedding human neutrophils mediated ber of physiological stimuli, including fMLP, A23187 and through the A receptor [146] . Data also suggest that 2a concanavalin A. Later studies determined that this inhibadenosine may inhibit the release of cytokines involved in itory effect was mediated by the A adenosine receptor responses to ischemia and reperfusion (IL-6 and IL-8) [142] . Therefore, 3 adenosine may play an important role in modulating local
The complement cascade, particularly the alternative inflammatory responses by its ability to either upregulate pathway, is activated during myocardial ischemia-reperfuor suppress the actions of neutrophils at the site of injury. sion and is a major contributor to the pathologic sequellae At concentrations achieved during ischemia or pharmacoof cardiopulmonary bypass [156] [157] [158] [159] [160] [161] . Complement fraglogically, the inhibitory responses predominate, resulting in ments, such as the anaphylatoxins C3a and C5a, are suppression of superoxide anion generation, degranulation generated and released both locally [162] and systemically and neutrophil adherence. [163, 164] and the membrane attack complex is deposited The role of adenosine in modulating reperfusion injury on cell membranes [165] . Ivey et al. [166] demonstrated in vivo has been extensively investigated, based largely on that the release of the complement fragment C5a is the purine's potent anti-neutrophil properties. Olaffson et associated with reperfusion, and C5a generation was al.
[150] first demonstrated a reduction in infarct size and associated with increased neutrophil accumulation in the improvement in regional function at 24 h reperfusion when area at risk. In ischemia-reperfusion, complement induces adenosine was administered at the onset of reperfusion.
injury directly, independent of neutrophils, and acts as Microscopic analysis demonstrated a significant reduction chemoattractant and activator of neutrophils and other in neutrophil accumulation and preservation of endothelial inflammatory cell types. Direct injury may be induced by morphology in the ischemic-reperfused myocardium in the C5a and via assembly of the membrane attack complex, group given adenosine at reperfusion. Subsequent studies thereby increasing cell permeability and cellular edema, have shown the beneficial effects of adenosine when given and increasing the release of histamine and PAF. at the onset of reperfusion, including reduction of infarct Tissue damage mediated by neutrophils can be initiated size [151, 152] , preservation of post-ischemic coronary by complement fragments, notably C5a, which are potent flow reserve [153] and blood flow [151] , post-ischemic stimulators of neutrophil superoxide production, and regional contractile performance [151, 153] , and reduction adherence to coronary artery endothelium [167] . Complein neutrophil accumulation in the area at risk [153] . The in ment increases the expression of CD18 on the neutrophil vivo reduction in reperfusion injury has been attributed [168, 169] and increases P-selectin expression on the primarily to A receptor-mediated processes [64, 154, 155] .
surface of the endothelium [170] . The chemoattractant 2a
In summary, adenosine has a broad spectrum of physioproperties of C5a cause neutrophil accumulation in vasculogical effects that make it suitable as a cardioprotective lar beds [171] and induce neutrophil-mediated reperfusion agent with effectiveness in all three windows of opporinjury. Shandelya et al. [172] showed that C5a or plasma tunity (pretreatment, during ischemia and reperfusion) and factors, most likely C5a, were necessary to induce neutroagainst numerous targets, including the neutrophil. The phil-mediated postischemic contractile dysfunction. Inhibiduration of the physiological actions seem to extend well tion of the complement cascade by inhibiting C1-esterase beyond its plasma half-life. In addition, adenosine reduces activity during reperfusion (responsible for cleavage of C1 reperfusion injury by inhibiting the neutrophil and the into C1r and C1s chains, and initiation of the complement endothelium directly, and their interactions with each cascade by C1s) has been shown by Buerke et reduce infarct size and attenuate neutrophil accumulation in a model of complement-mediated (human plasma) in the area at risk, with associated improvement in contractile dysfunction in an isolated-perfused rabbit heart coronary endothelial function. Amsterdam et al. [174] preparation, observed a reduction of postischemic contracreported that preischemic infusion of a monoclonal antitile dysfunction. Kouretas et al. [182] have suggested that body against C5a to reduce bio-availability of this fragthe cardioprotective effects manifested as preserved postment reduced infarct size in a porcine model of LAD ischemic contractile function involve nitric oxide, perhaps occlusion and reperfusion. However, the C5a antibody did through attenuation of coronary artery endothelial dysfuncnot reduce the accumulation of neutrophils in the area at tion effecting nitric oxide release. risk, although it reduced C5a-stimulated neutrophil aggregation, degranulation and superoxide anion formation in vitro. In a surgical model of reperfusion in which regional 7. Other anti-inflammatory therapy ischemia and cardiopulmonary bypass act as dual triggers for complement activation, Riley et al. [167] used a C5a
In addition to these newer therapeutic approaches to receptor antagonist to reduce infarct size. Concomitant reduce reperfusion injury, conventional anti-inflammatory with decreased infarction, there was a significant decrease treatments may also have potential benefit. Steroids have in neutrophil accumulation, as assessed by myeloperoxidbeen used to suppress inflammation for decades and there ase activity and improved postischemic (postcardioplegic)
is substantial evidence that they may reduce some of the regional contractile function in the area at risk (similar to mechanisms of injury induced by ischemia and reperfuthe improved function observed by Amsterdam et al.
sion. Suzuki et al. [183] demonstrated that hydrocortisone [174]). In a similar model, Tofukuji et al. [175] demondecreases the level of histamine-induced leukocyte adherstrated preservation of postcardioplegic endothelial funcence. Accordingly, leukocyte adherence induced by adtion when an anti-C5a antibody was given prior to the renalectomy was reduced with hydrocortisone therapy, onset of cardiopulmonary bypass.
suggesting a relation between steroid levels and leukocyte Complement receptor type 1 (CR-1) is an endogenous adhesion. Node et al.
[184] reduced infarct size and membrane-bound (red blood cells and leukocytes) postischemic arrhythmias in dogs treated with 17b-esglycoprotein regulator of complement activation (both tradiol. This protection appeared to be related to the alternative and classical pathways) through dissociation of production of nitric oxide and / or the activation of a the C3 and C5 convertases. A reduction in ischemiccalcium-dependent potassium channel. Other classic antireperfusion injury has been reported with the peptideinflammatory compounds, such as aspirin and ibuprofen, soluble complement receptor-1 (sCR-1). sCR-1 is able to have equivocal actions on reducing postischemic damage. inhibit both the classical and alternative pathways of the Seemingly equal numbers of studies have shown either a complement cascade. sCR-1 was reported to block combenefit [185-188] or no effect [189, 190] of these and other plement-mediated free-radical generation by neutrophils anti-inflammatory agents. However, it is difficult to de- [172] . Weisman et al.
[176] reported a significant reduction termine the true potential of these agents because of the in infarct size with sCR-1 in the rat model, which was wide range of endpoints used to determine their effectiveassociated with a reduction in both neutrophil accumulaness, including infarct size, ischemic and reperfusion tion and deposition of the membrane attack complex in the arrhythmias. area at risk. Similar reports have confirmed this cardioprotection with sCR-1 [172, 177, 178] .
Recently, heparin and heparin derivatives have shown 8. Summary remarks benefit in reducing myocardial ischemia-reperfusion injury. Heparin is a glycosaminoglycan produced by mast Neutrophils play an active role in myocardial ischemiacells and basophils, and is found as a major proteoglycan reperfusion injury. Interactions between neutrophils and component on the glycocalyx of vascular endothelium. In the coronary vascular endothelium, mediated by adhesion addition to its potent anticoagulant activity, heparin inhibmolecules on both cell types, are critical initial steps in the its the complement cascade at several sites, notably at the initiation of the inflammatory-like response. Therapeutics level of C3 convertase, resulting in attenuation of compledirected at specific stages in this inflammatory cascade are ment activation and leukocyte-mediated effects. Heparin effective in truncating the response, the benefit being a inhibits neutrophil adhesion to coronary vascular endoreduction in endothelial cell dysfunction and microvascular thelium, superoxide generation and chemotaxis, but, interblood flow defects, myocyte injury culminating in infarcestingly, it does not attenuate neutrophil degranulation. tion and, in some cases, contractile dysfunction. Since the Black et al. [179] , using heparin or N-acetyl heparin activation, propagation and amplification reactions of the administered just before reperfusion, reported a significant neutrophil-mediated inflammatory response to ischemia reduction in infarct size. Gralinski et al. [180] , using the and reperfusion are in a cascading sequence and are low molecular weight polysulfated heparin derivative LU exquisitely redundant, the more proximal the point in these 51198, and Friedrichs et al. [181] , using N-acetyl heparin molecular interactions (i.e. neutrophil-endothelial cell interactions) at which therapeutics can intervene, the less 261-277. likely that the point of interdiction will be circumvented.
[8] Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is
Hence, agents that interfere with the early P-selectininvolved in the breakdown of endothelium-derived relaxing factor. 
